Skip to main content

Advertisement

SpringerLink
Log in

Recognizing Unusual Manifestations of Hodgkin Lymphoma

  • Lymphomas (J Armitage and P McLaughlin, Section Editors)
  • Published:
Current Hematologic Malignancy Reports Aims and scope Submit manuscript

Abstract

Hodgkin lymphoma (HL) is a rare malignancy of the lymphatic system that is curable in at least 80 % of patients. Although patients usually present with painless lymphadenopathy, a variety of systemic and organ-specific syndromes may also exist in relation to HL. These syndromes may develop before, during, or after the diagnosis of HL and may also indicate disease relapse. Most of these unusual disorders resolve with successful HL treatment but some may require adjunctive supportive therapies before a response is achieved. Oncologists should be familiar with these syndromes because early recognition may result in a more timely diagnosis of HL which may lead to improved outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interests, published recently, have been highlighted as: • Of importance

  1. • Bierman PJ, Cavalli F, Armitage JO. Unusual syndromes in Hodgkin Lymphoma. In: Hoppe RT, Mauch PT, Armitage JO, et al., editors. Hodgkin lymphoma. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 411–8. A thorough review of less-common manifestations of HL.

    Google Scholar 

  2. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin’s disease staging classification. Cancer Res. 1971;31:1860–1.

    PubMed  CAS  Google Scholar 

  3. Tubiana M, Attie E, Flamant R, et al. Prognostic factors in 454 cases of Hodgkin’s disease. Cancer Res. 1801;1971:31.

    Google Scholar 

  4. National Comprehensive Cancer Network: Hodgkin Lymphoma Guidelines. Available at: www.nccn.org.

  5. • Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99:4283–97. An analysis of the role of cytokines in HL, with particular attention to EBV related HL.

    Article  PubMed  CAS  Google Scholar 

  6. Yosipovitch G. Chronic pruritis: a paraneoplastic sign. Derm Ther. 2010;23:590–6.

    Article  Google Scholar 

  7. Olsson H, Brandt L. Relief of pruritis as an early sign of spinal cord compression in Hodgkin’s disease. Acta Med Scand. 1979;206:319.

    Article  PubMed  CAS  Google Scholar 

  8. Sonkoly E, Muller A, Lauerma AI, et al. IL-31: a new link between T cells and pruritis in atopic skin inflammation. J Allergy Clin Immunol. 2006;117:411–7.

    Article  PubMed  CAS  Google Scholar 

  9. Rubenstein M, Duvic M. Cutaneous manifestations of Hodgkin’s disease. Intern J Derm. 2006;45:251–6.

    Article  Google Scholar 

  10. Guitart J, Fretzin D. Skin as the primary site of Hodgkin’s disease and review of its relationship with non-Hodgkin’s lymphoma. Am J Dermatopathol. 1998;20:218.

    Article  PubMed  CAS  Google Scholar 

  11. Jurisic V, Bogunovic M, Colovic N, et al. Indolent course of cutaneous Hodgkin’s disease. J Cutan Pathol. 2005;32:176.

    Article  PubMed  Google Scholar 

  12. Mukesh M, Shuttleworth D, Murray P. Primary cutaneous Hodgkin’s lymphoma. Clin Derm. 2009, 673–5.

  13. White RM, Patterson JW. Cutaneous involvement in Hodgkin’s disease. Cancer. 1985;55:1136.

    Article  PubMed  CAS  Google Scholar 

  14. Simon S, Azevedo SJ, Bynes JJ. Erythema nodosum heralding recurrent Hodgkin’s disease. Cancer. 1985;56:1470.

    Article  PubMed  CAS  Google Scholar 

  15. • Grimm S, Chamberlain M. Hodgkin’s lymphoma: a review of neurologic complications. Adv Hem. 2011, Article ID 624578. A thorough review of paraneoplastic as well as non-paraneoplastic neurologic manifestations of HL.

  16. Strayer DR, Bender RA. Eosinophilic meningitis complicating Hodgkin’s disease. A report of a case and review of the literature. Cancer. 1977;40:406–9.

    Article  PubMed  CAS  Google Scholar 

  17. Bender BL, Mayernik DG. Hodgkin’s disease presenting with isolated craniospinal involvement. Cancer. 1986;58:1745–8.

    Article  PubMed  CAS  Google Scholar 

  18. Hammack J, Kotanides H, Rosenblum MD, et al. Paraneoplastic cerebellar degeneration: clinical and immunologic findings in 21 patients with Hodgkin’s disease. Neurology. 1992;42:1938–43.

    Article  PubMed  CAS  Google Scholar 

  19. Peltola J, Hietaharju A, Lehtinen T, et al. A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin’s disease. Acta Neurol Scand. 1998;98:360–3.

    Article  PubMed  CAS  Google Scholar 

  20. Smitt PS, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21–7.

    Article  Google Scholar 

  21. Zandi MS, Irani SR, Follows G, et al. Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. Neurology. 2009;73:2039–40.

    Article  PubMed  CAS  Google Scholar 

  22. Younes A, Bartlett NL, Leonard JP, et al. Brentuximab vedotin (SGN-35) for relapsed CD-30 positive lymphomas. N Engl J Med. 2010;363:1812–21.

    Article  PubMed  CAS  Google Scholar 

  23. Richmond J, Sherman RS, Diamond HD, et al. Renal lesions associated with malignant lymphomas. Am J Med. 1962;32:184.

    Article  PubMed  CAS  Google Scholar 

  24. Yum MN, Edwards JL, Kleit S. Glomerular lesions in Hodgkin’s disease. Arch Pathol. 1975;99:645.

    PubMed  CAS  Google Scholar 

  25. • Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin’s lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006;69:2251–60. A very descriptive and large case series that explains clinical features and outcomes of patients with HL and MCNS.

    Article  PubMed  CAS  Google Scholar 

  26. • Audard V, Zhang S, Copie-Bergman C, et al. Occurance of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes. Blood. 2010;115:3756–62. An experimental explanation of the pathophysiology of MCNS in HL.

    Article  PubMed  CAS  Google Scholar 

  27. Ronco PM. Paraneoplastic glomerulonephropathies: new insignts into an old entity. Kidney Int. 1999;56:355–77.

    Article  PubMed  CAS  Google Scholar 

  28. Hohaus S, Massini G, Giachelia M, et al. Anemia in Hodgkin’s lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol. 2010;28:2538–43.

    Article  PubMed  CAS  Google Scholar 

  29. • Lechner K, Chen Y. Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma. Leuk Lymphoma. 2010;51:469–74. A thorough review of autoimmune cytopenias in HL.

    Article  PubMed  CAS  Google Scholar 

  30. Xiros N, Binder T, Anger B, et al. Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in Hodgkin’s disease. Eur J Haematol. 1988;40:437.

    Article  PubMed  CAS  Google Scholar 

  31. Hudson BV, Linch DC, MacIntyre EA, et al. Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin’s disease (BNLI Report No 31). J Clin Pathol. 1987;40:247–50.

    Article  Google Scholar 

  32. Von Wasielewski R, Seth S, Franklin J, et al. Tissue eosinophilia correlates strongly with poor prognosis nodular sclerosing Hodgkin’s disease, allowing for known prognostic factors. Blood. 2000;95:1207–13.

    Google Scholar 

  33. Menard F, Besson C, Rince P, et al. Hodgkin lymphoma-associated hemophagocytic syndrome: a disorder strongly correlated with Epstein-Barr virus. Clin Infect Dis. 2008;47:531–4.

    Article  PubMed  Google Scholar 

  34. Seifter EJ, Parker RI, Gralnick HR, et al. Abnormal coagulation results in patients with Hodgkin’s disease. Am J Med. 1985;78:942–50.

    Article  PubMed  CAS  Google Scholar 

  35. Slease RB, Schumacher HR. Deficiency of coagulation factors VII and XII in a patient with Hodgkin’s disease. Arch Intern Med. 1977;137:1633–5.

    Article  PubMed  CAS  Google Scholar 

  36. Fahey JL, Rahbar S, Farbstein MJ, et al. Microcytosis in Hodgkin disease associated with unbalanced globin chain synthesis. 2006;23:123–9.

  37. Rieke JW, Donaldson SS, Horning SJ. Hypercalcemia and vitamin D metabolism in Hodgkin’s disease. Cancer. 1989;63:1700.

    Article  PubMed  CAS  Google Scholar 

  38. Walters EG, Denton RM, Tavare JM, et al. Hypoglycemia due to an insulin-receptor antibody in Hodgkin’s disease. Lancet. 1987;1:241.

    Article  PubMed  CAS  Google Scholar 

  39. Nadiminiti Y, Wang JC, Chou SY, et al. Lactic acidosis associated with Hodgkin’s disease. N Engl J Med. 1980;303:15–7.

    Article  Google Scholar 

  40. Banerjee D. Recent advances in the pathobiology of Hodkin’s lymphoma: potential impact on diagnostic, predictive, and therapeutic strategies. Adv Hem. 2011, Article ID 439456.

  41. Ballonoff A, Kavanagh B, Nash R, et al. Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review. Acta Oncol. 2008;47:962–70.

    Article  PubMed  Google Scholar 

  42. Barta SK, Yahalom J, Shia J, et al. Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin’s lymphoma. Clin Lymphoma Myeloma. 2006;7:77–82.

    Article  PubMed  Google Scholar 

  43. Tubiana M, Henry-Amar M, Hayat M, et al. Prognostic significance of the number of involved areas in the early stages of Hodgkin’s Disease. Cancer. 1984;54:885–94.

    Article  PubMed  CAS  Google Scholar 

  44. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med. 1998;339:1506–14.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. University of Nebraska Medical Center Section of Oncology/Hematology, 987680 Nebraska Medical Center, Omaha, NE, 68198-7680, USA

    Nicholas A. Barber & Philip J. Bierman

Authors
  1. Nicholas A. Barber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip J. Bierman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicholas A. Barber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barber, N.A., Bierman, P.J. Recognizing Unusual Manifestations of Hodgkin Lymphoma. Curr Hematol Malig Rep 7, 186–192 (2012). https://doi.org/10.1007/s11899-012-0131-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11899-012-0131-4

Keywords

Search

Navigation